Nurses are often seen as first line responders when it comes to care delivery within hospitals and health systems. It therefore comes as no surprise that interruptions and distractions are the rule of thumb—not the exception—for nursing activity. It’s common for clinicians or family members to stop a nurse more than once while he or she pulls medications from an automated dispensing cabinet (ADC...
Human error and contamination are the most common patient safety risks for any pharmacy compounding operation – and often the most serious. It then follows that best practices for compounding focus on two primary goals: accuracy and sterility. The healthcare industry at large recognizes that higher standards of practice stem from minimizing the potential for human error. Which begs the question...
It’s time for nurses to ask the question: How safe are the IVs I’m administering to my patients? Pharmacists and nurses share common patient safety goals—summarized nicely within the Five Rights of Medication Administration. In a nutshell, the expectation is that clinical processes will work together to reduce medication errors by ensuring administration of: The right drug At the right dose To...
Are you reaping the significant opportunities associated with the 340B Drug Pricing Program (340B)? For the average 350-bed eligible hospital, 340B offers $1-$6 million annually in savings, which can mean the difference between staying open or closing. But adherence to this is continually evolving and the federal law can be complicated. As the industry heads into 2016, we’re on a mission to...
USP has proposed significant changes to General Chapter <797> Pharmaceutical Compounding – Sterile Preparations that will impact your sterile compounding service. With public comment on the proposed chapter due to USP by January 31, 2016, it is important that you understand the proposed changes and submit your comments and concerns for consideration as USP formulates their final...
It’s been a great week here at the 50th ASHP Midyear Clinical Meeting & Exhibition. In talking with my peers throughout the week, it is abundantly clear that in this dynamic and continually changing healthcare environment we must think differently to create a strong vision for the future. Now more than ever, pharmacy leadership needs to ensure that their strategy and efforts align to the...
Imagine if you had a comprehensive, real-time view of all medication inventory across all of your care facilities. Our healthcare partners are doing more than just imagining it. They’re leveraging real-time technologies to optimize workflows, effectively manage drug shortages and significantly reduce costs. Early adopters of Aesynt’s Enterprise Medication ManagerTM are achieving significant cost...
Reliable. Meaningful. Specific. This is the Food and Drug Administration’s mantra for stability testing of IV compounded medications, which in turn formally sets the bar for beyond use dating. As we team with progressive hospitals and health systems to support insourced sterile compounding, it’s apparent that the right automation and beyond use dating strategy can produce higher-quality...
Welcome to New Orleans and the 50th ASHP Midyear Clinical Meeting & Exhibition.  50 years ago, the very first Midyear meeting had 254 registrants.  Today, ASHP expects more than 20,000 pharmacy professionals from over 100 countries to attend.  While the meeting has grown substantially in size, the core goal remains: bringing health system pharmacists together with industry professionals to...
What could you do if you had comprehensive, real-time insight into all existing medication inventory? I recently explored this question during Aesynt’s customer meeting, Building Bridges, where I had the opportunity to present lessons learned from our experiences at Aultman.  I shared with the audience how the right medication management strategy can benefit patient care, while simultaneously...